Primary peritoneal serous papillary carcinoma: a case series

Area of Science:

• Oncology
• Gynecologic Oncology
• Cancer Research

Background:

• Primary peritoneal serous papillary carcinoma (PPSPC) is an uncommon gynecologic malignancy.
• It shares similarities with epithelial ovarian cancer in terms of histology and behavior.
• Early diagnosis and appropriate management are crucial for patient outcomes.

Purpose of the Study:

• To describe the clinical and laboratory features of PPSPC patients.
• To outline the management strategies employed for PPSPC.
• To report on the outcomes of PPSPC treatment.

Main Methods:

• Retrospective analysis of 19 PPSPC patients treated between 2002 and 2017.
• Patients underwent debulking surgery followed by first-line chemotherapy.
• Data collected included clinical presentation, biomarkers (CA125, HE4), Peritoneal Cancer Index, and survival.

Main Results:

• Median patient age was 66 years; common symptoms included abdominal distention and pain.
• All patients had elevated CA125 levels (median 565 U/ml).
• Median overall survival was 29 months for patients staged IIIC/IVA, treated with paclitaxel/carboplatin, with bevacizumab added in recent cases.

Conclusions:

• PPSPC is a rare malignancy requiring specialized care.
• Management should occur in tertiary oncology centers for optimal patient outcomes.